bpc-157 clinical trial human dosing Dosage Protocol: Injection Guide bpc-157 clinical trial human dosing

Add it to your cart and check out securely pay by Interac e-Transfer, no account needed

Note: Weekly doses should not exceed 4.5 mg, and rotating injection sites is recommended to lower the risk of localized adverse effects

Surgery is a stress

Clinical insight: European Journal of Pharmacology (2023) found BPC-157 significantly reduced tissue necrosis and vascular damage in ischemic injury models

If you are having side effects at your current dose, do not increase your dosage until those side effects have resolved

Both are dosed subQ Same daily injection schedule No known stability conflict Synergistic: BPC-157 targets soft tissue (tendons, gut, ligaments), TB-500 (thymosin beta-4) addresses systemic healing and mobility Draw BPC-157 first, then TB-500 into the same syringe